Royal Bank of Canada’s CERo Therapeutics CERO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1
Closed 7727
2025
Q3
$0 Buy
+1
New +$7 ﹤0.01% 7593

Royal Bank of Canada's CERO Position: Q4 2025 in Review

Royal Bank of Canada sold out of CERo Therapeutics (CERO) in Q4 2025, closing a stake of 1 share.

Royal Bank of Canada first reported a position in CERO in Q3 2025 and held it in 1 quarter. The position peaked at $0 in Q3 2025. 0 funds tracked by Wall St. Rank hold CERO as of Q4 2025.

  • Royal Bank of Canada reported no remaining CERo Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Royal Bank of Canada sold 1 CERo Therapeutics share in Q4 2025.
  • Royal Bank of Canada first reported a position in CERo Therapeutics in Q3 2025 and held it in 1 quarter.
  • Royal Bank of Canada's CERo Therapeutics position peaked at $0 in Q3 2025.
  • 0 funds tracked by Wall St. Rank held CERo Therapeutics as of Q4 2025.

Based on Royal Bank of Canada's 13F filing for Q4 2025, filed 17 Feb 2026.